Chloroacetic Acid

Chloroacetic Acid

SCHEMBL4587654

O=C([O-])CCl.O=C([O-])CCl.[Mg+2]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ATP4AATP4BGABBR1GABBR2HMGCR

The experimentally established mechanism targets of Chloroacetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CA4 P22748 6/20 0.47
TSHR P16473 1/20 0.47
CASP1 P29466 1/20 0.41
FFAR3 O14843 2/20 0.37
HDAC3 O15379 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC2 Q92769 2/20 0.37
HDAC8 Q9BY41 2/20 0.37
CA1 P00915 1/20 0.33
BBOX1 O75936 1/20 0.33
CA2 P00918 1/20 0.33
FAHD1 Q6P587 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chloroacetic Acid SCHEMBL6348583 0.96
Chloroacetic Acid SCHEMBL6342133 0.96
Chloroacetic Acid SCHEMBL21752872 0.96 CA4 (0.50) CA4TSHRCASP1FFAR3HDAC3
Chloroacetic Acid SCHEMBL6908147 0.92 CA4 (0.47) CA4TSHRCASP1FFAR3HDAC3
Chloroacetic Acid SCHEMBL21752985 0.92 CA4 (0.47) CA4TSHRCASP1FFAR3HDAC3
Chloroacetic Acid SCHEMBL8587680 0.92 CA4 (0.47) CA4TSHRCASP1FFAR3HDAC3
Chloroacetic Acid SCHEMBL379061 0.92 CA4 (0.47) CA4TSHRCASP1FFAR3HDAC3
Chloroacetic Acid SCHEMBL21752867 0.92
Chloroacetic Acid SCHEMBL8608083 0.92 CA4 (0.47) CA4TSHRCASP1FFAR3HDAC3
Chloroacetic Acid SCHEMBL6915345 0.92 CA4 (0.47) CA4TSHRCASP1FFAR3HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11434379-B2 Composition, its preparation process, and the use of the composition as a waterproofing coat BASF SE (DE) 2022-09-06 US claimed
US-20220081509-A1 A COMPOSITION COMPRISING METHYLENE MALONATE MONOMER AND POLYMER, THE PREPARATION THEREOF AND USE OF THE SAME IN UNDERGROUND CONSTRUCTIONS BASF SE (DE) 2022-03-17 US claimed
CN-114058173-A Process and composition for producing flexible polyurethane foams 赢创运营有限公司 2022-02-18 CN claimed
EP-3954722-A1 PROCESS AND COMPOSITION FOR THE PRODUCTION OF FLEXIBLE POLYURETHANE FOAM Evonik Operations GmbH (DE) 2022-02-16 EP claimed
US-20220033603-A1 PROCESS AND COMPOSITION FOR THE PRODUCTION OF FLEXIBLE POLYURETHANE FOAM EVONIK OPERATIONS GMBH (DE) 2022-02-03 US claimed
CN-113454169-A Compositions comprising methylene malonate monomers and polymers, methods of making the same, and uses thereof in subterranean construction 巴斯夫欧洲公司 2021-09-28 CN claimed
US-20210222118-A1 CHARCOAL-FREE CULTURE MEDIA FOR LEGIONELLA Secretary of State for Health and Social Care (GB) 2021-07-22 US claimed
EP-3841214-A1 CHARCOAL-FREE CULTURE MEDIA FOR LEGIONELLA Secretary of State for Health and Social Care (GB) 2021-06-30 EP claimed
CN-112888790-A Legionella carbon-free culture medium 英国卫生与社会保障部 2021-06-01 CN claimed
EP-3153530-B1 COMPOSITE AND LAMINATE ARTICLES AND POLYMERIZABLE SYSTEMS FOR PRODUCING THE SAME SIRRUS INC (US) 2021-02-24 EP claimed
CN-112074497-A Composition, process for its preparation and use of the composition as a water-repellent coating 巴斯夫欧洲公司 2020-12-11 CN claimed
CN-111801306-A Compositions containing methylene malonate monomers and polymers, their preparation and their use in flooring applications 巴斯夫欧洲公司 2020-10-20 CN claimed
WO-2020039213-A1 CHARCOAL-FREE CULTURE MEDIA FOR LEGIONELLA Secretary of State for Health and Social Care (GB) 2020-02-27 WO claimed
EP-2831125-B1 METHODS FOR ACTIVATING POLYMERIZABLE COMPOSITIONS, POLYMERIZABLE SYSTEMS, AND PRODUCTS FORMED THEREBY SIRRUS INC (US) 2016-10-05 EP claimed
EP-2831124-B1 COMPOSITE AND LAMINATE ARTICLES AND POLYMERIZABLE SYSTEMS FOR PRODUCING THE SAME SIRRUS INC (US) 2016-10-05 EP claimed
JP-10158547-A None JP disclosed
EP-3805327-B1 ANTIFOULING PAINT COMPOSITION MITSUBISHI CHEM CORP (JP) 2026-04-15 EP disclosed
JP-H10158547-A ANTIFOULING COATING MATERIAL COMPOSITION MITSUBISHI RAYON CO LTD 1998-06-16 JP disclosed
EP-0754669-A1 PROCESSES FOR PRODUCING ALPHA-HALO KETONES, ALPHA-HALOHYDRINS AND EPOXIDES KANEKA CORPORATION (JP) 1997-01-22 EP disclosed
US-4313850-A METAL BIS(HALOCARBOXYLATE), OXYGENATED ORGANOTITANIUM, VANDIUM OR ZIRCONIUM COMPOUND AND AN ORGANOALUMIUM COMPOUND STANDARD OIL COMPANY (INDIANA) (US) 1982-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220033603-A1 PROCESS AND COMPOSITION FOR THE PRODUCTION OF FLEXIBLE POLYURETHANE FOAM PUF60, FUS, PCBP1 CA4 1901/4885TSHR 4315/4885CASP1 3427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.